[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-385614-105":59,"doc-detail-385614-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","delivering-genetic-testing-for-patients-with-prostate-cancer-moving-beyond-provider-knowledge-as-a-barrier-to-care","Delivering Genetic Testing for Patients with Prostate Cancer - Moving Beyond Provider Knowledge as a Barrier to Care","","The article examines how expanded national guidelines for prostate cancer germline genetic testing changed provider practice beyond major cancer centers. A qualitative study of multidisciplinary providers at a safety-net hospital used interviews and thematic analysis. Results highlight barriers to identifying eligible patients, including lack of routine identification systems and limited accessible family history data, alongside non-medical referral influences such as health literacy, language, cultural beliefs, distress, and cost. Digital technologies may help but not fully remove access challenges.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/delivering-genetic-testing-for-patients-with-prostate-cancer-moving-beyond-provider-knowledge-as-a-barrier-to-care/385614/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/delivering-genetic-testing-for-patients-with-prostate-cancer-moving-beyond-provider-knowledge-as-a-barrier-to-care/385614.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-24",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the article address about prostate cancer genetic testing?","Question",{"text":112,"@type":113},"It investigates how guideline-driven expansion of genetic services affected provider practice outside large cancer centers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What were key challenges providers reported in identifying eligible patients?",{"text":117,"@type":113},"Providers cited insufficient systems for routine patient identification and limited readily available family history data needed for eligibility decisions.",{"name":119,"@type":110,"acceptedAnswer":120},"How might digital technologies improve genetic testing referral access?",{"text":121,"@type":113},"Providers suggested that systematically identifying eligible patients through digital tools could mitigate some, but not all, of the barriers found in the study.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},385614,1790901374,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","| Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care | Cancer Control Volume 30: 1–10\u003Cbr>© The Author(s) 2023\u003Cbr>Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)\u003Cbr>[DOI: 10.1177/10732748221143884](DOI: 10.1177/10732748221143884)[ ](DOI: 10.1177/10732748221143884)[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Christine M. Gunn, MA, PhD 1,2,3 􀀁, Emma X. Li, MSc4, Gretchen A. Gignac, MD4,5, Magdalena Pankowska, MPH2, Stephanie Loo, MSc3, Kimberly Zayhowski, MSc5, and Catharine Wang, MSc, PhD6\u003Cbr>Abstract\u003Cbr>Introduction: The 2018 National Comprehensive Cancer Network guidelines for prostate cancer genetic testing expanded access to genetic services. Few studies have examined how this change has affected provider practice outside of large cancer centers.\u003Cbr>Methods: We conducted a qualitative study of multi-disciplinary health care providers treating patients with prostate cancer ata safety-net hospital. Participants completed an interview that addressed knowledge, practices, and contextual factors related to providing genetic services to patients with prostate cancer. A thematic analysis using both inductive and deductive coding was undertaken.\u003Cbr>Results: Seventeen providers completed interviews. Challenges in identifying eligible patients for genetic testing stemmed from a lack of a) systems that facilitate routine patient identification, and b) readily available family history data for eligibility determination. Providers identified non-medical patient characteristics that influenced their referral process, including health literacy, language, cultural beliefs, patient distress, and cost. Providers who see patients at different times along the cancer care continuum viewed benefits of testing differently.\u003Cbr>Conclusion: The use of digital technologies that systematically identify those eligible for genetic testing referrals may mitigate some but not all challenges identified in this study. Further research should determine how individual provider perceptionsinfluence referral practices and patient access to genetics both within and across cancer specialties.\u003Cbr>Keywords\u003Cbr>prostatic neoplasms, genetic testing, practice guidelines, safety-net providers, qualitative research, bias |  |\n| 1 Geisel School of Medicine at Dartmouth, The Dartmouth Institute for Health Policy and Clinical Practice and Dartmouth Cancer Center, Lebanon, NH, USA 2Evans Department of Medicine, Section of General Internal Medicine, Boston University Aram V. Chobanian & Edward Avedisian School of Medicine, Boston, MA, USA\u003Cbr>3Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, USA\u003Cbr>4Evans Department of Medicine, Boston University Aram V. Chobanian & Edward Avedisian School of Medicine, Boston, MA, USA\u003Cbr>5Evans Department of Medicine, Section of Hematology and Oncology, Boston University Aram V. Chobanian & Edward Avedisian School of Medicine, Boston, MA, USA\u003Cbr>6Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA\u003Cbr>Corresponding Author:\u003Cbr>Christine M. Gunn, Geisel School of Medicine at Dartmouth, The Dartmouth Institute for Health Policy and Clinical Practice and Dartmouth Cancer Center, 1Medical Center Drive, WTRB 527, Lebanon, NH 03756, USA.\u003Cbr>[Email:](Email: Christine.M.Gunn@dartmouth.edu)[ Christine.M.Gunn@dartmouth.edu](Email: Christine.M.Gunn@dartmouth.edu) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([","cbCaiuTwBNq7CNrn","https://ap.wps.com/l/cbCaiuTwBNq7CNrn","pdf",592870,"English","# Abstract\n## Introduction\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What problem does the article address about prostate cancer genetic testing?\",\"answer\":\"It investigates how guideline-driven expansion of genetic services affected provider practice outside large cancer centers.\"},{\"question\":\"What were key challenges providers reported in identifying eligible patients?\",\"answer\":\"Providers cited insufficient systems for routine patient identification and limited readily available family history data needed for eligibility decisions.\"},{\"question\":\"How might digital technologies improve genetic testing referral access?\",\"answer\":\"Providers suggested that systematically identifying eligible patients through digital tools could mitigate some, but not all, of the barriers found in the study.\"}]","Delivering Genetic Testing for Patients with Prostate Cancer - Moving Beyond Provider Knowledge as a Barrier to Care | PDF",1790270228,25]